已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Evaluation and prediction of relapse risk in stable systemic lupus erythematosus patients after glucocorticoid withdrawal (PRESS): an open-label, multicentre, non-inferiority, randomised controlled study in China

医学 羟基氯喹 内科学 临床终点 随机对照试验 系统性红斑狼疮 疾病 传染病(医学专业) 2019年冠状病毒病(COVID-19)
作者
Yunyun Fei,Lidan Zhao,Lijun Wu,Xiaoxia Zuo,Rongli Li,Jiaomei Cheng,Hui Luo,Xue Wu,Li Yan Sun,Jingjing Xu,Yingxuan Zhu,Yang Wang,Zhu Chen,Xiaomei Li,Xiaofei Wang,Xuan Zhang
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:84 (2): 274-283 被引量:17
标识
DOI:10.1136/ard-2024-225826
摘要

Objectives

To explore the relapse rate after glucocorticoid (GC) withdrawal with or without hydroxychloroquine (HCQ) maintenance in sustained clinically inactive systemic lupus erythematosus (SLE).

Methods

The PRESS trial is a multicentre, 33-week, open-label, three-arm, non-inferiority designed, randomised controlled trial. SLE patients with sustained clinically inactive disease who were maintained on low-dose GC plus HCQ therapy were screened and qualified patients were randomly assigned to three groups: drug-free group (both GC and HCQ withdrawal); HCQ group (discontinued GC but maintained HCQ); dual maintenance group (both GC and HCQ continued). The primary endpoint was to compare the proportion of patients experiencing a relapse as defined by the Safety of Estrogens in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index flare index by 33 weeks. Two parallel non-inferiority analyses were performed (drug-free group vs dual maintenance group and HCQ group vs dual maintenance group).

Results

From 3 November 2016 to 13 August 2021, 333 participants complied with the protocol after randomisation were analysed. The relapse rates in the three groups were 26.1%, 11.2% and 4.7%, respectively. Compared with dual maintenance group, drug-free group failed to achieve non-inferiority significance (relapse rate difference 21.4%; 95% CI 12.3% to 30.5%; Pnon-inferiority=0.238), whereas HCQ group achieved non-inferiority (relapse rate difference 6.5%; 95% CI −0.5% to 13.5%; Pnon-inferiority=0.034). HCQ group also exhibited fewer relapses than drug-free group (p=0.006). Adverse events were similar among all three groups.

Conclusions

GC withdrawal may be feasible in sustained clinically inactive SLE patients. HCQ maintenance can exert a protective role in preventing disease relapse after GC withdrawal.

Trial registration number

NCT02842814.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SzMg完成签到,获得积分10
2秒前
武渊思完成签到,获得积分10
2秒前
CodeCraft的应助被LLL采纳,获得10
4秒前
花花完成签到 ,获得积分10
5秒前
嘻嘻哈哈的应助被zs采纳,获得10
5秒前
xinyuanjia的应助被明理的音响采纳,获得10
6秒前
张真源完成签到 ,获得积分10
6秒前
地兮完成签到 ,获得积分10
7秒前
勤劳的康乃馨完成签到 ,获得积分10
7秒前
我爱行楷完成签到,获得积分10
8秒前
SciGPT的应助被黑桃Q采纳,获得10
8秒前
宫城良官完成签到 ,获得积分10
8秒前
结实的翠芙完成签到,获得积分10
10秒前
易只羊完成签到,获得积分10
10秒前
泉汀野和完成签到,获得积分10
11秒前
Abandon1完成签到 ,获得积分10
12秒前
重要盼易完成签到,获得积分10
15秒前
闪闪松鼠完成签到 ,获得积分10
15秒前
16秒前
winwin完成签到 ,获得积分10
17秒前
17秒前
17秒前
愉快续完成签到 ,获得积分10
17秒前
无奈的迎丝完成签到 ,获得积分10
18秒前
微笑大象完成签到,获得积分10
18秒前
MySun完成签到 ,获得积分10
20秒前
lx完成签到,获得积分10
20秒前
零听发布了新的文献求助20
21秒前
爆米花的应助被欢呼的安白采纳,获得10
21秒前
强健的若云完成签到 ,获得积分10
22秒前
xinyuanjia的应助被bb采纳,获得10
23秒前
丘比特的应助被初一采纳,获得10
23秒前
重要元灵完成签到 ,获得积分10
23秒前
黑桃Q发布了新的文献求助10
24秒前
Akim的应助被詹詹采纳,获得10
24秒前
在水一方的应助被扶光hjgkk采纳,获得10
24秒前
24秒前
tomatoGG发布了新的文献求助10
25秒前
今后的应助被alongi3采纳,获得30
26秒前
芒果在散步完成签到 ,获得积分10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179439
求助须知:如何正确求助?哪些是违规求助? 9569878
关于积分的说明 21807236
捐赠科研通 7774891
什么是DOI,文献DOI怎么找? 3433032
关于科研通互助平台的介绍 2556999
邀请新用户注册赠送积分活动 2478741